Phase 2 Lung Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults over 18 years old who have been diagnosed with non-small cell lung cancer (a type of lung cancer), confirmed by a laboratory test on a tissue sample, and who are planned to receive immunotherapy — either alone or combined with other treatments — for advanced or spread cancer.
- People who have cancer that can be measured on scans or imaging.
- People whose general health and ability to carry out daily activities falls within a certain range, from fully active to capable of limited self-care (confirm with trial site for exact details).
Who may not be able to join:
- People who have other serious health conditions that, in the opinion of the trial doctor, could interfere with the goals of the trial.
- People who are pregnant or currently breastfeeding.
- People who experience severe claustrophobia (extreme fear of enclosed spaces), which may affect their ability to undergo certain scans.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Muhammad Furqan, M.D., Holden Comprehensive Cancer Center
Phone: 319-356-1445
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
[18F]F-AraG Test - Re Test
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.